Athira Pharma Inc Stock price
Is Athira Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Athira Pharma Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a Athira Pharma Inc forecast:
Analyst Opinions
7 Analysts have issued a Athira Pharma Inc forecast:
Don't miss a Thing! We will send you all news about Athira Pharma Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Athira Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company was founded by Leen Kawas and Joseph Harding in 2011 and is headquartered in Seattle, WA.
| Head office | United States |
| CEO | Dr. Litton |
| Employees | 26 |
| Founded | 2011 |
| Website | www.athira.com |


